ANAHEIM, Calif., Feb. 11, 2015-Solvay, a leading global supplier of high-performance thermoplastics, andTSO3Inc., a leading developer of low-temperature sterilization systems for the healthcare industry, jointly announced today that, as part of the U.S. FDA's 510(k) premarket clearance for TSO3's newSTERIZONE® VP4 Sterilization Systemreceived in December 2014, light weight instrument trays made of Solvay Specialty Polymer'sRadel® polyphenylsulfone(PPSU) resin demonstrate strong compatibility for sterilizing a wide range of medical devices.

The STERIZONE® VP4 Sterilizer developed by TSO3is a low-temperature sterilization s ystem that utilizes vaporized hydrogen peroxide and ozone. It is the only system to have received FDA's premarket clearance for dual sterilant processes. It can sterilize a large number and wide range of compatible devices in a cost-effective, error-free single cycle. TSO3's unique Dynamic Sterilant Delivery System™ automatically adjusts the quantity of injected sterilant based on the load composition, weight and temperature. With its large, 75-pound (34-kilogram) capacity and short cycle time, the STERIZONE® VP4 Sterilizer can enhance throughput and lower sterilization costs.

"TSO3's sterilant delivery technology represents significant value to our customers by offering them the option to select standard, highly durable, light weight instrument trays made from Solvay's high-performance Radel® material and, as a result, lower their inventories and costs," said R.M. (Ric) Rumble, president and CEO of TSO3.

"The growing use of electronics, flexible endoscopes and other delicate medical devices that are incompatible with high-temperature steam sterilization has increased the need for low-temperature sterilization techniques, such as hydrogen peroxide gas," said Dane Waund, global healthcare market manager for Solvay Specialty Polymers. "To support this growing demand, Solvay conducted extensive studies to confirmRadel® PPSU'sstrong compatibility with TSO3's unique sterilization technology."

Solvaywill be showcasing its broad selection of high-performance medical-grade polymers for medical devices atMedical Design & Manufacturing (MD&M) West 2015in booth #1906, from Feb. 10-12.

STERIZONE is a registered trademark of TSO3
Dynamic Sterilant Delivery System is a trademark of TSO3

About TSO3

Founded in 1998, TSO3's activities encompass research, development, commercialization and licensing of sterilization processes for heat-sensitive medical devices, related equipment, accessories and consumable supplies. TSO3designs products for sterile processing areas in the hospital environment and offers an advantageous replacement solution to other low temperature sterilization processes currently used in hospitals. For more information about TSO3, visit the Company's Web site atwww.tso3.com.

The statements in this release and oral statements made by representatives of TSO3relating to matters that are not historical facts (including, without limitation, those regarding the timing or outcome of any financing undertaken by TSO3) are forward-looking statements that involve certain risks, uncertainties and hypotheses, including, but not limited to, general business and economic conditions, the condition of the financial markets, the ability of TSO3to obtain financing on favourable terms and other risks and uncertainties.

The TSX has neither approved nor disapproved the information contained herein and accepts no responsibility for it.

About Solvay Specialty Polymers

Solvay Specialty Polymers manufactures over 1500 products across 35 brands of high-performance polymers - fluoropolymers, fluoroelastomers, fluorinated fluids, semi-aromatic polyamides, sulfone polymers, aromatic ultra polymers, high-barrier polymers and cross-linked high-performance compounds - for use in Aerospace, Alternative Energy, Automotive, Healthcare, Membranes, Oil and Gas, Packaging, Plumbing, Semiconductors, Wire and Cable, and other industries. Learn more atwww.solvay.com.

As an international chemical group,SOLVAYassists industries in finding and implementing ever more responsible and value-creating solutions. Solvay generates 90% of its net sales in activities where it is among the world's top three players. It serves many markets, varying from energy and the environment to automotive and aeronautics or electricity and electronics, with one goal: to raise the performance of its clients and improve society's quality of life. The group is headquartered in Brussels, employs about 29,400 people in 56 countries and generated 9.9 billion euros in net sales in 2013. Solvay SA (SOLB.BE) is listed on EURONEXT Brussels and EURONEXT Paris (Bloomberg:SOLB:BB- Reuters:SOLB.BR).

distributed by